Treatment of Cervical Spinal Cord Injury with a drug called Imatinib – a study to check the uptake of the study drug in the blood and the safety of the study drug for these patients.

Registry ID

EUCTR2014-002170-36

Source registry

EUCTR

Status

Ongoing

Phase

PHASE2

Sponsor

Karolinska University Hospital

Start date

2015-02-11

Last update

2026-08-16

Conditions

• Cervical Spinal Cord Injury

Summary

To evaluate the uptake of Imatinib in acute Cervical Spinal Cord Injury patients by measuring blood levels of Imatinib and by observing Imatinib-induced increased levels of three cytokines in blood.

Locations

• , , Sweden

Related clinical trials

• Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
• Robot-assisted vs. Conventional Occupational Therapy of the Upper Limb in Individuals With Cervical Spinal Cord Injury
• Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Tablet-01)
• Spinal Cord Associative Plasticity Study
• Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord Injuries
• Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury

View on source registry